Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1968-2-16
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0570-4944
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
754-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4864720-Aged,
pubmed-meshheading:4864720-Cerebrovascular Disorders,
pubmed-meshheading:4864720-Clinical Trials as Topic,
pubmed-meshheading:4864720-Female,
pubmed-meshheading:4864720-Humans,
pubmed-meshheading:4864720-Male,
pubmed-meshheading:4864720-Middle Aged,
pubmed-meshheading:4864720-Thiethylperazine,
pubmed-meshheading:4864720-Vertigo
|
pubmed:year |
1967
|
pubmed:articleTitle |
The use of thiethylperazine (Torecan) in disorders of balance due to cerebrovascular accidents.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|